Showing results (31-40 of 35) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Arthritis Research & Therapy|January 31, 2019
Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritisDafna D Gladman, Ana-Maria Orbai, Uta Klitz, et al.BMC Rheumatology|March 20, 2019
Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivityLaura C Coates, Ana-Maria Orbai, Akimichi Morita, et al.Rheumatology (Oxford, England)|June 27, 2018
Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1)Alice B Gottlieb, Vibeke Strand, Mitsumasa Kishimoto, et al.Rheumatology and Therapy|December 5, 2020
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)Ana-Maria Orbai, Jordi Gratacós, Anthony Turkiewicz, et al.The Journal of Rheumatology|December 17, 2018
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical TrialsAna-Maria Orbai, Richard Holland, Ying Ying Leung, et al.Pageof 4